Lekhak N, Bhattarai H
Cancer Control. 2024; 31:10732748241302902.
PMID: 39629692
PMC: 11615997.
DOI: 10.1177/10732748241302902.
Singh H, Mishra A, Mohanto S, Kumar A, Mishra A, Amin R
Ann Med Surg (Lond). 2024; 86(10):5877-5913.
PMID: 39359831
PMC: 11444613.
DOI: 10.1097/MS9.0000000000002392.
Abutayeh R, Altah M, Mehdawi A, Al-Ataby I, Ardakani A
Curr Issues Mol Biol. 2024; 46(7):6600-6619.
PMID: 39057035
PMC: 11276303.
DOI: 10.3390/cimb46070393.
Panahizadeh R, Vatankhah M, Safari A, Danesh H, Nazmi N, Gholizadeh P
Cancer Cell Int. 2024; 24(1):234.
PMID: 38970040
PMC: 11225148.
DOI: 10.1186/s12935-024-03430-1.
Golonko A, Olichwier A, Szklaruk A, Paszko A, Swislocka R, Szczerbinski L
Molecules. 2024; 29(11).
PMID: 38893482
PMC: 11174085.
DOI: 10.3390/molecules29112603.
Targeted Inhibition of the PI3K/Akt/mTOR Signaling Axis: Potential for Sarcoma Therapy.
Wani A, Singh R, Akhtar N, Prakash A, Nepovimova E, Oleksak P
Mini Rev Med Chem. 2024; 24(16):1496-1520.
PMID: 38265369
DOI: 10.2174/0113895575270904231129062137.
Resources for Human Health from the Plant Kingdom: The Potential Role of the Flavonoid Apigenin in Cancer Counteraction.
Fossatelli L, Maroccia Z, Fiorentini C, Bonucci M
Int J Mol Sci. 2024; 25(1).
PMID: 38203418
PMC: 10778966.
DOI: 10.3390/ijms25010251.
Therapeutic potential of natural products in inflammation: underlying molecular mechanisms, clinical outcomes, technological advances, and future perspectives.
Gouda N, Alshammari S, Abourehab M, Alshammari Q, Elkamhawy A
Inflammopharmacology. 2023; 31(6):2857-2883.
PMID: 37950803
DOI: 10.1007/s10787-023-01366-y.
Translating Senotherapeutic Interventions into the Clinic with Emerging Proteomic Technologies.
Dey A, Banarjee R, Boroumand M, Rutherford D, Strassheim Q, Nyunt T
Biology (Basel). 2023; 12(10).
PMID: 37887011
PMC: 10604147.
DOI: 10.3390/biology12101301.
Combined Deep Learning and Molecular Modeling Techniques on the Virtual Screening of New mTOR Inhibitors from the Thai Mushroom Database.
Posansee K, Liangruksa M, Termsaithong T, Saparpakorn P, Hannongbua S, Laomettachit T
ACS Omega. 2023; 8(41):38373-38385.
PMID: 37867669
PMC: 10586184.
DOI: 10.1021/acsomega.3c04827.
Transglutaminase 3 suppresses proliferation and cisplatin resistance of cervical cancer cells by inactivation of the PI3K/AKT pathway.
Chen R, Fang T, Liu N, Shi X, Wang J, Yu H
Naunyn Schmiedebergs Arch Pharmacol. 2023; 397(4):2269-2280.
PMID: 37812238
DOI: 10.1007/s00210-023-02757-2.
Concurrent induction of apoptosis and necroptosis in apigenin‑treated malignant mesothelioma cells: Reversal of Warburg effect through Akt inhibition and p53 upregulation.
Lee Y, Park K, Heo S, Cho M, Lee S
Oncol Rep. 2023; 49(6).
PMID: 37083070
PMC: 10170486.
DOI: 10.3892/or.2023.8548.
Apigenin improves cytotoxicity of antiretroviral drugs against HTLV-1 infected cells through the modulation of AhR signaling.
Sales D, Lin E, Stoffel V, Dickson S, Khan Z, Beld J
NeuroImmune Pharm Ther. 2023; 2(1):49-62.
PMID: 37027342
PMC: 10070013.
DOI: 10.1515/nipt-2022-0017.
Intracellular Pathways and Mechanisms of Colored Secondary Metabolites in Cancer Therapy.
Sevastre A, Manea E, Popescu O, Tache D, Danoiu S, Sfredel V
Int J Mol Sci. 2022; 23(17).
PMID: 36077338
PMC: 9456420.
DOI: 10.3390/ijms23179943.
Pharmacological Properties of 4', 5, 7-Trihydroxyflavone (Apigenin) and Its Impact on Cell Signaling Pathways.
Abid R, Ghazanfar S, Farid A, Sulaman S, Idrees M, Amen R
Molecules. 2022; 27(13).
PMID: 35807549
PMC: 9267958.
DOI: 10.3390/molecules27134304.
Anticancer Effects and Molecular Mechanisms of Apigenin in Cervical Cancer Cells.
Chen Y, Wu J, Yang S, Yang C, Chen T, Hsiao Y
Cancers (Basel). 2022; 14(7).
PMID: 35406599
PMC: 8998024.
DOI: 10.3390/cancers14071824.
Berberine exerts its antineoplastic effects by reversing the Warburg effect via downregulation of the Akt/mTOR/GLUT1 signaling pathway.
Guo X, Jiang S, Zhang L, Hu J, Edelbek D, Feng Y
Oncol Rep. 2021; 46(6).
PMID: 34643248
PMC: 8548812.
DOI: 10.3892/or.2021.8204.
Anti-Cancer Activity of Phytochemicals Targeting Hypoxia-Inducible Factor-1 Alpha.
Yun B, Son S, Choi S, Kuh H, Oh T, Park J
Int J Mol Sci. 2021; 22(18).
PMID: 34575983
PMC: 8467787.
DOI: 10.3390/ijms22189819.
Apigenin Inhibits the Histamine-Induced Proliferation of Ovarian Cancer Cells by Downregulating ERα/ERβ Expression.
Liu M, Zhang Y, Xu Q, Liu G, Sun N, Che H
Front Oncol. 2021; 11:682917.
PMID: 34568014
PMC: 8456091.
DOI: 10.3389/fonc.2021.682917.
Effects of Apigenin and Apigenin- Loaded Nanogel on Induction of Apoptosis in Human Chronic Myeloid Leukemia Cells.
Samadian N, Hashemi M
Galen Med J. 2021; 7:e1008.
PMID: 34466424
PMC: 8344127.
DOI: 10.22086/gmj.v0i0.1008.